List of Abbreviations: |
Full Name: |
α-SMA |
α- smooth muscle actin |
ADT |
Androgen-deprivation therapy |
AR |
Androgen Receptor |
ASPN |
Asporin |
BCR |
Biochemical recurrence |
BM |
Bone metastasis |
BMPs |
Bone morphogenetic proteins |
BPH |
Benign prostatic hyperplasia |
CAFs |
Cancer-associated fibroblasts |
CD |
Cluster of designation antigens |
CRPC |
Castration-resistant prostate cancer |
CXCL |
Chemokine (C-X-C motif) ligand |
CXCR |
Chemokine (C-X-C motif) receptor |
ECM |
Extracellular matrix |
EMT |
Epithelial to mesenchymal transition |
EVs |
Extracellular vesicles |
FAP |
Fibroblast activation protein |
FGFs |
Fibroblast growth factors |
FSP-1 (also known as S100A4) |
Fibroblast-specific protein-1 |
GDF15 |
Growth differentiation factor 15 |
HGF |
Hepatocyte growth factor |
HSCs |
Hematopoietic stem cells |
IGFs |
Insulin-like growth factors |
ILs |
Interleukins |
MFBs |
Myofibroblasts |
MMPs |
Matrix metalloproteinases |
OB-BMST |
Osteoblastic bone metastasis-associated stroma transcriptome |
PCa |
Prostate cancer |
PDGFR |
Platelet-derived growth factor receptor |
PIA |
Proliferative inflammatory atrophy |
PIN |
Prostatic intraepithelial neoplasia |
POSTN |
Periostin |
PSA |
Prostate-specific antigen |
ROS |
Reactive-oxygen species |
TGF-β |
Transforming growth factor -β |
TGFβRII |
TGF-β receptor type II |
TIMPs |
Tissue inhibitors of matrix metalloproteinases |
TME |
Tumor microenvironment |
TNC |
Tenascin C |
VEGF |
Vascular endothelial growth factor |